Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. (SCNI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SCNI · as of Jun 9, 2026
Key Statistics
Explore Scinai Immunotherapeutics Ltd. Data
scni stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
scni competitorsSCNI
AZTR
ENVB
INDP
JSPR
ONCOStock Performance
Full HistoryAbout Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary obje…
what is scinai immunotherapeutics ltd. · scni stock overview · scinai immunotherapeutics ltd. company profile · who is scinai immunotherapeutics ltd. ceo · scni NASDAQ · scinai immunotherapeutics ltd. headquarters · scinai immunotherapeutics ltd. business segments
About Stock Overview & Key Data
Scinai Immunotherapeutics Ltd. (SCNI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 11, 2015. As of the latest trading session, SCNI stock price is $0.36, with a market capitalization of $474,321. The stock has returned -83.56% over the past 12 months and -42.76% year-to-date.
In fiscal year 2025, Scinai Immunotherapeutics Ltd. reported revenue of $1.3M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Scinai Immunotherapeutics Ltd. (SCNI) stock price is $0.36. The stock is traded on NASDAQ under the ticker symbol SCNI. The 52-week range is $0.36 – $3.48.